Literature DB >> 16344486

Stereostructure of luminamicin, an anaerobic antibiotic, via molecular dynamics, NMR spectroscopy, and the modified Mosher method.

Hiroaki Gouda1, Toshiaki Sunazuka, Hideaki Ui, Masaki Handa, Yusuke Sakoh, Yuzuru Iwai, Shuichi Hirono, Satoshi Omura.   

Abstract

The absolute stereostructure of luminamicin, an anaerobic antibiotic, has been determined by using conformational analysis via high-temperature molecular dynamics, NMR spectroscopy, and the modified Mosher method. It was found that luminamicin has the S, S, R, R, R, R, S, S, S, R, and S configurations at C2, C4, C7, C9, C10, C11, C12, C13, C16, C28, and C29, respectively. This configuration is the same as that found in nodusmicin, which has a chemical structure quite similar to luminamicin. The structure of luminamicin consists of three different rings, i.e., a decalin ring, a 10-membered macrolactone ring, and a 14-membered macrolactone ring. The resulting three-dimensional structure of luminamicin shows an interesting feature in that the maleic anhydride functionality in conjugation with the enol ether group of the 14-membered macrolactone is nearly perpendicular to the plane of the other two rings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344486      PMCID: PMC1317948          DOI: 10.1073/pnas.0508425102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  CAMDAS: an automated conformational analysis system using molecular dynamics. Conformational Analyzer with Molecular Dynamics And Sampling.

Authors:  H Tsujishita; S Hirono
Journal:  J Comput Aided Mol Des       Date:  1997-05       Impact factor: 3.686

2.  Luminamicin, a new antibiotic. Production, isolation and physico-chemical and biological properties.

Authors:  S Omura; R Iwata; Y Iwai; S Taga; Y Tanaka; H Tomoda
Journal:  J Antibiot (Tokyo)       Date:  1985-10       Impact factor: 2.649

3.  Chloropeptins I and II, novel inhibitors against gp120-CD4 binding from Streptomyces sp.

Authors:  K Matsuzaki; H Ikeda; T Ogino; A Matsumoto; H B Woodruff; H Tanaka; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1994-10       Impact factor: 2.649

4.  Chloropeptins, new anti-HIV antibiotics inhibiting gp120-CD4 binding from Streptomyces sp. II. Structure elucidation of chloropeptin I.

Authors:  K Matsuzaki; T Ogino; T Sunazuka; H Tanaka; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1997-01       Impact factor: 2.649

5.  Lustromycin, a new antibiotic produced by Streptomyces sp.

Authors:  H Tomoda; R Iwata; Y Takahashi; Y Iwai; R Oiwa; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1986-09       Impact factor: 2.649

6.  Clostomicins, new antibiotics produced by Micromonospora echinospora subsp. armeniaca subsp. nov. I. Production, isolation, and physico-chemical and biological properties.

Authors:  S Omura; N Imamura; R Oiwa; H Kuga; R Iwata; R Masuma; Y Iwai
Journal:  J Antibiot (Tokyo)       Date:  1986-10       Impact factor: 2.649

7.  Coloradocin, an antibiotic from a new Actinoplanes. II. Identity with luminamicin and elucidation of structure.

Authors:  R R Rasmussen; M H Scherr; D N Whittern; A M Buko; J B McAlpine
Journal:  J Antibiot (Tokyo)       Date:  1987-10       Impact factor: 2.649

8.  Thiotetromycin, a new antibiotic. Taxonomy, production, isolation, and physicochemical and biological properties.

Authors:  S Omura; Y Iwai; A Nakagawa; R Iwata; Y Takahashi; H Shimizu; H Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1983-02       Impact factor: 2.649

  8 in total
  3 in total

1.  Toward the total synthesis of luminamicin; an anaerobic antibiotic: construction of highly functionalized cis-decalin containing a bridged ether moiety.

Authors:  Hiroyasu Ando; Aoi Kimishima; Motoyoshi Ohara; Tomoyasu Hirose; Takanori Matsumaru; Hirokazu Takada; Keisuke Morodome; Takehiro Miyamoto; Akihiro Sugawara; Satoshi Ōmura; Toshiaki Sunazuka
Journal:  J Antibiot (Tokyo)       Date:  2017-07-05       Impact factor: 2.649

2.  A [6+4]-cycloaddition adduct is the biosynthetic intermediate in streptoseomycin biosynthesis.

Authors:  Kai Biao Wang; Wen Wang; Bo Zhang; Xin Wang; Yu Chen; Hong Jie Zhu; Yong Liang; Ren Xiang Tan; Hui Ming Ge
Journal:  Nat Commun       Date:  2021-04-07       Impact factor: 14.919

3.  Apoptotic Activity of New Oxisterigmatocystin Derivatives from the Marine-Derived Fungus Aspergillus nomius NC06.

Authors:  Muh Ade Artasasta; Yanwirasti Yanwirasti; Muhammad Taher; Akmal Djamaan; Ni Putu Ariantari; Ru Angelie Edrada-Ebel; Dian Handayani
Journal:  Mar Drugs       Date:  2021-11-11       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.